LivaNova’s (LIVN) “Buy” Rating Reiterated at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of LivaNova (NASDAQ:LIVN) in a report published on Monday,Benzinga reports. Needham & Company LLC currently has a $75.00 price target on the stock.

LIVN has been the subject of several other reports. Mizuho cut their target price on shares of LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. The Goldman Sachs Group initiated coverage on shares of LivaNova in a report on Friday, October 4th. They issued a “buy” rating and a $65.00 price objective for the company. StockNews.com lowered shares of LivaNova from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 16th. Robert W. Baird raised their target price on LivaNova from $66.00 to $72.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Finally, Baird R W raised LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 17th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, LivaNova has a consensus rating of “Buy” and an average target price of $69.17.

LivaNova Stock Up 3.5 %

Shares of LIVN opened at $52.48 on Monday. The company has a market capitalization of $2.85 billion, a price-to-earnings ratio of 124.95 and a beta of 1.01. LivaNova has a 52 week low of $42.75 and a 52 week high of $64.47. The stock’s 50-day moving average price is $52.21 and its 200-day moving average price is $52.30. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46.

Institutional Investors Weigh In On LivaNova

Institutional investors have recently bought and sold shares of the company. Point72 Asset Management L.P. lifted its position in shares of LivaNova by 204.3% in the second quarter. Point72 Asset Management L.P. now owns 1,285,636 shares of the company’s stock valued at $70,479,000 after acquiring an additional 863,157 shares in the last quarter. First Light Asset Management LLC boosted its stake in LivaNova by 591.1% during the 2nd quarter. First Light Asset Management LLC now owns 710,390 shares of the company’s stock worth $38,944,000 after purchasing an additional 607,598 shares during the last quarter. Great Lakes Advisors LLC purchased a new stake in shares of LivaNova during the second quarter worth $16,614,000. Driehaus Capital Management LLC grew its holdings in shares of LivaNova by 64.7% during the second quarter. Driehaus Capital Management LLC now owns 544,042 shares of the company’s stock worth $29,824,000 after buying an additional 213,749 shares in the last quarter. Finally, Point72 DIFC Ltd raised its position in shares of LivaNova by 75,799.6% in the third quarter. Point72 DIFC Ltd now owns 181,400 shares of the company’s stock valued at $9,531,000 after buying an additional 181,161 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.